Iofina Share Discussion Threads

[captain_kurt] 23/12/2013 07:32

Well said H, the bears may have to pack up their picnic now :@)

[semper vigilans] 23/12/2013 07:30

Have they got the water permit or not?
Badly written RNS.

[mail2] 23/12/2013 07:24

nice rns. hope you all get a nice rise in share price today maybe put a lot of last week aside.

[1madmarky] 23/12/2013 07:14

Yep,gaining water rights is a process, so all to pay for.

[captain_kurt] 23/12/2013 07:07

A giant step forward in getting the permit awarded.

[orslega] 23/12/2013 07:05

23 December 2013

Iofina plc

(LSE AIM: IOF)

Water Project Update

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce that a meeting with the Montana Department of Natural Resources and Conservation has been set for January 30, 2014 to review the Group's non-core water rights application.

As requested by the State of Montana, and following a review by the Company's retained consultants, the meeting will discuss the engineering design on the water depot and the letters of intent for the water usage. The Board will update shareholders in due course.

For further information, please contact:

George Lantz, CEO

Iofina plc

[naphar] 22/12/2013 23:12

They never actually confirmed that though Fresh.

[freshvoice] 22/12/2013 23:02

Rugrat

I thought 6 was to take surplus from 2? Surely it has to be VERY close to do that?

[rugrat2] 22/12/2013 22:54

Bobsworth

My feeling is that IO#6 is sited with IO#4 which I am 99.9% certain is at Midstates Dacoma swd, a mile north of Dacoma and 3 miles by road from IO#2, and 8 miles from IO#3.

[napoleon 14th] 22/12/2013 22:21

LOLOL Huricane.
I agree.

& that FT article is quite provoking but in a sane way.

[naphar] 22/12/2013 22:09

Bobsworth,
The recent RNS said this:
"Construction on IO#6 has commenced with the decision to proceed with a site in close proximity of the Group's IO#2 and IO#3 plants."

That suggests to me that IO6 is not on the IO2 site but close to it, as is IO3

[mail2] 22/12/2013 21:43

simon gordon

sorry re reporter. noticed someone copy and pasted your comments on another board.

[bobsworth] 22/12/2013 21:27

Yes and looking forward to a solid recovery as folks realise this has only one way to go at this price with IOF#4,5 & 6 and a significant water sales rights rapidly coming to fruition in a relatively short period of time. Mind boggles at what IOF#6 will produce on the IOF#2 site!

[hurricane.] 22/12/2013 21:17

I hope the bears enjoyed their picnic.
Short and sweet. It's about to change.

[simon gordon] 22/12/2013 21:00

mail2,

No reporter is comparing IOF with Langbar, you are taking one of my posts out of context.

Here is the FT piece:

FT - 22/12/13:

Why iodine may be needed to bathe shareholders' wounds

Small Talk's 2013 award for volatility goes to iodine extractor Iofina

V is for victory and vociferousness. But also volatility.

This year's Small Talk award for vociferousness goes to the Aim team at the London Stock Exchange, for lobbying the government until it agreed to let private investors put Aim shares into individual savings accounts.

Small Talk's less sought-after 2013 award for volatility goes to Iofina, the Aim-quoted darling of bulletin boards and private investors who own about half of the shares. Iofina, which extracts iodine from waste water from the shale oil industry for use in anything from disinfectants to paints and computer screens, is typical of small, speculative enterprises on Aim that catch hobbyist investors' eyes. Its share price chart illustrates just what a mixed blessing it can be for a share register to include hordes of private investors.

Iofina's shares – which Chris Fay, the group's ebullient chairman, says are the most heavily traded on Aim – more than doubled between January and May to about 245p. Then in June, they fell 40 per cent in a day for no reason that the company could think of. They veered between 150p and 200p until an update last week knocked another one-third of the price. At 86p, the shares are lower than they were a year ago.

That is despite the company's proving that its patented technology to extract iodine works and at a fraction of the cost of other producers.

This year Iofina rolled out three plants in the US and reported first-half revenues 50 per cent higher with pre-tax losses narrowed from $1m to $0.1m.

The fourth and fifth plants are now on track to begin pumping the purple stuff in early 2014 and construction of the sixth has started. Consensus forecasts suggest pre-tax profits will be more than £25m by December 2014 and £40m the year after.

That said, last week's update was disappointing, emphasising that Iofina is still at an early stage. The company warned that delays in booking sales meant full-year revenues and earnings would do no more than match last year's. It is clear that Iofina's long-term success rests on tying down reliable flows of dirty water from other energy companies on profitable terms. It also has to find markets for its raw and refined product.

Iofina may yet become one of America's biggest producers of purple crystals, but it will still be dwarfed by rivals in Chile and Japan which churn out four-fifths of the world's supplies.

The challenge for all small companies is to sell the positive news without over-promising.

For Iofina's board, the challenge is greater because so many shares are held by private investors. Institutional investors understand the risks in ventures such as Iofina. They have deep pockets and can sit out bouts of turbulence. Private investors may not have that luxury.

The LSE argued that giving private investors greater access to the junior market would lift trading volumes, ease liquidity and reinvigorate share prices of Aim companies.

The quid pro quo is that Aim boards must work harder on managing expectations. Either that – or keep the iodine on hand to cleanse their, and their shareholders', wounds.

[mail2] 22/12/2013 20:50

i see danger when a reporter is comparing iof to langbar.

[monty panesar] 22/12/2013 15:59

Seeing is believing sometimes and good to see pictures of IO4/5 under construction on the website. Looks as if both might be completed in about a month.I think each plant takes around 60 days to build. At least they only take 3 days off for Christmas.

[mail2] 22/12/2013 14:35

IOF...previous two takes "in question" so yes sometimes the tea leaves don't work for some and Sue again was correct so I'm eating humble pie and not for the first time...for now previous support is resistance and markets normally over-react after bad news...but several bad news events can make the effect "sick" for now I have 75p as bounce zone and 50p as invest for breakout of falling wedge zone....not saying it will get there but if it did then I'd have some as reward vs risk from chart pespective appealing....for now we may see 50p or 116 so only traders playing this and that usually means it will take some time "for the dust to settle" 75p trading bounce seems logical to me.

[heavyhaulage49] 22/12/2013 13:34

I think we shall see a sustained recovery of the share price from now on as the basics of the company concerning its technology are sound.
Don't have the time to catch up on the enormous amount of posts I have missed but some of the regular contributors seem to be gone from here looking at the few posts I have read.

[uppompeii] 22/12/2013 13:21

They're not worth that now neddo...

[neddo] 22/12/2013 13:05

21/12/13

Director deals: Iofina chairman Fay bags over £150,000 worth of shares


It has been a rough week for iodine producer Iofina (LON:IOF) with the share price down around 33% in the last five trading days.

[napoleon 14th] 21/12/2013 18:22

Fair comments, all 5, imo.
Markets now are SO different from when I started some 40 years ago...
Much more heat thru' exposure, media, computers & www.
IOF got into very hot water, but as I hold MOS & GBO, it's just more of the same.

[bocker01] 21/12/2013 18:15

I see that article as deliberately trying to mislead regarding cash. The substition effect of using own product means that during H2 2013 the company will have washed its face over the loss of credit terms and got a small positive cash benefit on top of it. This effect was totally ignored by the writer and is massively significant. This effect will be far more pronounced in H1 2014 and imo after allowing for cap-x at the same levels as H1 2013, the company will be broadly cash nuetral unitil it sells to third parties. It will then be sitting on a large cash pile of which a proportion will be used to finance debtors. Based on margins achieved this will reverse quickly. Having said this cap-x will be largely complete until a new roll out phase. Further with no risk to cash, imo there is no risk of going out of business therefore ultimately third part sales will cause profitability to rise quickly. Timing may be an issue or may not be an issue, but ultimately I believe the foundations to be strong. Anyway, it could always factor its debt for a period and use the cash for other things whatever they maybe.

[meadow2] 21/12/2013 18:06

Putting on my rose-tinted glasses and trusting that the relatively new CEO, George Lantze, is being much more realistic than of late, I've read with care his comments.

"Whilst we expect revenues and EBITDA to be comparable to 2012, 2013 has seen the successful deployment of Iofina's IOsorb technology along with the continued growth of its derivatives business. Taking stock of the iodine production opportunities, increased derivative sales and prilling that are open to Iofina, 2014 signifies an exciting year for the rapidly expanding Group."

Perhaps there is more than hope!